Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Oliver Weigert, Nadja Kopp et al.|The Lancet Oncology|2015Cited by 613
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H. Durham, Omar Abdel‐Wahab, Estibaliz Lopez Rodrigo et al.|Nature Medicine|2019Cited by 228
Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLLAlessandro Pastore, Dan A. Landau|Nature Communications|2019Cited by 84
Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II TrialSimone Ferrero, Alessandro Pastore, Christian W. Scholz et al.|Leukemia|2015Cited by 12